It’s a great pleasure to invite you to the "3rd International Congress on Neurobiology, Psychopharmacology and Treatment Guidance", which is taking place in Thessaloniki, Greece at the Met Hotel, on May 30th - June 2nd, 2013.
After the great success of the 2nd Congress which took place in 2011, this third congress aims again at being useful for the clinician who fights daily in the front line for the treatment of real-world patients. In this frame, our goal is to provide a global and comprehensive update of the newest developments in Psychiatry and the allied sciences in a way which will be both focused and enriched. The rule is to avoid content-free eloquence and authority and to face hard questions on the base of research findings. Many world wide experts have been invited to share with us their knowledge and experience once again under the support and guidance of the European Psychiatric Association and the World Psychiatric Association under the Auspices of the School of Medicine, Aristotle University of Thessaloniki.
During these difficult times, advanced education and training is the only way to future. Teaching clinical usefulness and application of new knowledge and informed treatment with psychopharmacological agents in a truly multidisciplinary approach is the central axis of the meeting and although the congress will embrace high tech research concerning psychopathology, new treatment methods, genetics and molecular biology, it also aims to put the emphasis on the human factor, both the therapist and the patient.
Apart from the humanistic tradition of Psychiatry and the life sciences, the continuous and unconditional investment in high level training of professionals and education of patients and their families, emerged as a significant challenge during the last few decades. Medical scientists and public health policy makers are increasingly concerned that the scientific discoveries are failing to be translated into tangible human benefit. Today the human factor emerges again as the most valuable one, the factor that determines the final outcome.
The main topics of the congress are the following:
- Animal Models
- Anxiety disorders
- Basic Neuroscience
- Behavioural disorders
- Biological rhythms
- Biomedical Technology
- Childhood and adolescence disorders
- Clinical Psychiatry
- Clinical Psychopharmacology
- Drug development
- Eating disorders
- Evidence-based psychiatry
- Experimental Psychopharmacology
- Forensic Psychiatry
- Health Economics and Quality of Life
- Information technology and neuroscience
- Learning abilities and disabilities
- Major disaster and mental health
- Memory and cognitive disorders
- Methodology in Psychiatric research
- Molecular Psychiatry
- Mood disorders
- Neural Networks
- Non pharmacological biological therapies
- Nosology and classification
- Psychiatric Genetics
- Psychosocial and other non-biological therapies and interventions
- Schizophrenia and other psychotic disorders
- Sexual behaviour and disorders
- Social Psychiatry
- Substance abuse and dependence
- Transcultural Psychiatry
- Treatment guidelines
The International Society on Neurobiology and Psychopharmacology announces 5 awards for the 5 best posters which will be presented during the conference. The winners will receive a honorary diploma. All submitted posters are considered candidates for the awards, unless otherwise stated by the author(s).
The Congress will be accredited with CME credits for the main congress program, by the European Accreditation Council for Continuing Medical Education (EACCME) Institution of the UEMS, to provide CME activity for medical specialists, recognized by the American Medical Association (AMA).